Trade Summary

3 days ago, Barton Shane, serving as Principal Accounting Officer at BioAge Labs, Inc. (BIOA), sold 62,566 shares at $25.20 per share, for a total transaction value of $1,576,752.09.

This sale represents a 100.00% decrease in Barton Shane's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 at 4:27 PM ET, 2 days after the trade was made.

BioAge Labs, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.